N1-methyladenosine methylation-related metabolic genes signature and subtypes for predicting prognosis and immune microenvironment in osteosarcoma

N1-methyladenosine methylation-related metabolic genes signature and subtypes for predicting prognosis and immune microenvironment in osteosarcoma

N1-methyladenosine methylation (m1A), as an important RNA methylation modification, regulates the development of many tumours. Metabolic reprogramming is one of the important features of tumour cells, and it plays a crucial role in tumour development and metastasis. The role of RNA methylation and m...

Full description

Bibliographic Details
Main Authors:	Guowei Wang, Hongyi Wang, Sha Cheng, Xiaobo Zhang, Wanjiang Feng, Pan Zhang, Jianlong Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Genetics
Subjects:	N1-methyladenosine methylation metabolism osteosarcoma immune infiltration immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.993594/full

Similar Items

Prediction of Prognosis and Immunotherapy of Osteosarcoma Based on Necroptosis-Related lncRNAs
by: Guowei Wang, et al.
Published: (2022-05-01)

N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma
by: Zhongguang Wu, et al.
Published: (2022-01-01)

Novel insight of N6-methyladenosine modified subtypes in abdominal aortic aneurysm
by: Kangjie Wang, et al.
Published: (2022-11-01)

Regulatory Role of N6-methyladenosine (m6A) Modification in Osteosarcoma
by: Yujie Zhang, et al.
Published: (2021-05-01)

N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
by: Di Zheng, et al.
Published: (2022-02-01)

A glycometabolic gene signature associating with immune infiltration and chemosensitivity and predicting the prognosis of patients with osteosarcoma
by: Fengyan Wang, et al.
Published: (2023-05-01)

Unfolded Protein Response–Related Signature Associates With the Immune Microenvironment and Prognostic Prediction in Osteosarcoma
by: Zhao Zhang, et al.
Published: (2022-06-01)

Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma
by: Rui Liu, et al.
Published: (2021-11-01)

An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer
by: Tianming Ma, et al.
Published: (2021-11-01)

Gene Expression Classifier Reveals Prognostic Osteosarcoma Microenvironment Molecular Subtypes
by: Yi-Jiang Song, et al.
Published: (2021-04-01)

Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma
by: Jianhao Li, et al.
Published: (2020-06-01)

Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma
by: Zhongyue Liu, et al.
Published: (2022-12-01)

Role of N6-methyladenosine methylation in glioma: recent insights and future directions
by: Chunlin Li, et al.
Published: (2023-12-01)

Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction
by: Long Xie, et al.
Published: (2023-02-01)

N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma
by: Tianming Ma, et al.
Published: (2021-10-01)

A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma
by: Hao Yang, et al.
Published: (2021-08-01)

A ubiquitin-related gene signature for predicting prognosis and constructing molecular subtypes in osteosarcoma
by: Nan Wei, et al.
Published: (2022-08-01)

The role of SPI1-TYROBP-FCER1G network in oncogenesis and prognosis of osteosarcoma, and its association with immune infiltration
by: Jiahua Li, et al.
Published: (2022-01-01)

Expression of m6A Regulators Correlated With Immune Microenvironment Predicts Therapeutic Efficacy and Prognosis in Gliomas
by: Shengchao Xu, et al.
Published: (2020-11-01)

N6-Methyladenosine-Related Gene Signature Associated With Monocyte Infiltration Is Clinically Significant in Gestational Diabetes Mellitus
by: Runyu Du, et al.
Published: (2022-03-01)

Identification of an EMT‐related gene‐based prognostic signature in osteosarcoma
by: Haoli Gong, et al.
Published: (2023-06-01)

Different Subtypes of Osteosarcoma: Histopathological Patterns and Clinical Behaviour
by: Emel Rothzerg, et al.
Published: (2023-05-01)

The role of mitochondria-related lncRNAs in characterizing the immune landscape and supervising the prognosis of osteosarcoma
by: Yiming Zhang, et al.
Published: (2023-12-01)

A Novel Pyroptosis-Related Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Osteosarcoma
by: Yiming Zhang, et al.
Published: (2021-11-01)

Analysis of Immune–Stromal Score-Based Gene Signature and Molecular Subtypes in Osteosarcoma: Implications for Prognosis and Tumor Immune Microenvironment
by: Dingzhao Zheng, et al.
Published: (2021-09-01)

The emerging roles of N6-methyladenosine RNA methylation in human cancers
by: Huafei Shen, et al.
Published: (2020-06-01)

Molecular subtype identification and predictive power of N6-methyladenosine regulator in unexplained recurrent pregnancy loss
by: Jiahui Huo, et al.
Published: (2022-09-01)

Cancer-associated fibroblast infiltration in osteosarcoma: the discrepancy in subtypes pathways and immunosuppression
by: Zhang Zhihao, et al.
Published: (2023-06-01)

m7G-related genes predict prognosis and affect the immune microenvironment and drug sensitivity in osteosarcoma
by: Zili Lin, et al.
Published: (2023-08-01)

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
by: Liting Guo, et al.
Published: (2021-12-01)

N6-methyladenosine RNA methylation: From regulatory mechanisms to potential clinical applications
by: Peipei Li, et al.
Published: (2022-11-01)

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
by: Mingyi Yang, et al.
Published: (2022-07-01)

Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer
by: Qiang Liu
Published: (2022-01-01)

Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma
by: Wenshuo Zhang, et al.
Published: (2022-12-01)

Development and Verification of a Hypoxic Gene Signature for Predicting Prognosis, Immune Microenvironment, and Chemosensitivity for Osteosarcoma
by: Fengfeng Wu, et al.
Published: (2022-01-01)

Integrative analysis of immune‐related multi‐omics profiles identifies distinct prognosis and tumor microenvironment patterns in osteosarcoma
by: Deyao Shi, et al.
Published: (2022-06-01)

Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
by: Weifeng Hong, et al.
Published: (2020-03-01)

N6-methyladenosine-related microRNAs risk model trumps the isocitrate dehydrogenase mutation status as a predictive biomarker for the prognosis and immunotherapy in lower grade gliomas
by: Feng Yuan, et al.
Published: (2022-09-01)

Immune Landscape of the Tumor Microenvironment Identifies Prognostic Gene Signature CD4/CD68/CSF1R in Osteosarcoma
by: Yi-jiang Song, et al.
Published: (2020-07-01)

Significance of N6-methyladenosine RNA methylation regulators in diagnosis and subtype classification of primary Sjögren’s syndrome
by: Jiaoyan Li, et al.
Published: (2024-02-01)